Moderna
MRNA
#1830
Rank
HK$84.22 B
Marketcap
HK$215.56
Share price
8.67%
Change (1 day)
-35.49%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2025 (TTM): -HK$24.51 Billion

According to Moderna 's latest financial reports the company's current earnings are HK$2.20 Billion. In 2024 the company made an earning of -HK$27.89 Billion, an increase over its 2023 earnings that were of -HK$30.39 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$24.51 Billion-12.11%
2024 -HK$27.89 Billion-8.22%
2023 -HK$30.39 Billion-140.65%
2022 HK$74.73 B-27.81%
2021 HK$103.52 B-1911.15%
2020 -HK$5.72 Billion44.7%
2019 -HK$3.95 Billion28.63%
2018 -HK$3.08 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regulus Therapeutics
RGLS
-HK$0.37 Billion-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$179.68 B-834.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-HK$0.33 Billion-98.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$1.01 B-104.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$127.76 B-622.07%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Arrowhead Pharmaceuticals
ARWR
-HK$0.59 Billion-97.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$252.09 B-1,130.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-HK$0.92 Billion-96.26%๐Ÿ‡บ๐Ÿ‡ธ USA